TY - JOUR
T1 - E unum pluribus
T2 - multiple proteins from a self-processing polyprotein
AU - de Felipe, Pablo
AU - Luke, Garry A.
AU - Hughes, Lorraine E.
AU - Gani, David
AU - Halpin, Claire
AU - Ryan, Martin D.
N1 - Funding Information:
Antibodies against 2A were generously provided by D.A.A. Vignali (St. Jude Children's Research Hospital, Memphis, USA; www.stjude.org ). The authors wish to acknowledge the long-term support by the BBSRC ( www.bbsrc.ac.uk ) and the Wellcome Trust ( www.welcome.ac.uk ).
PY - 2006/2
Y1 - 2006/2
N2 - Many applications of genetic engineering require transformation with multiple (trans)genes, although to achieve these using conventional techniques can be challenging. The 2A oligopeptide is emerging as a highly effective new tool for the facile co-expression of multiple proteins in a single transformation step, whereby a gene encoding multiple proteins, linked by 2A sequences, is transcribed from a single promoter. The polyprotein self-processes co-translationally such that each constituent protein is generated as a discrete translation product. 2A functions in all the eukaryotic systems tested to date and has already been applied, with great success, to a broad range of biotechnological applications: from plant metabolome engineering to the expression of T-cell receptor complexes, monoclonal antibodies or heterodimeric cytokines in animals.
AB - Many applications of genetic engineering require transformation with multiple (trans)genes, although to achieve these using conventional techniques can be challenging. The 2A oligopeptide is emerging as a highly effective new tool for the facile co-expression of multiple proteins in a single transformation step, whereby a gene encoding multiple proteins, linked by 2A sequences, is transcribed from a single promoter. The polyprotein self-processes co-translationally such that each constituent protein is generated as a discrete translation product. 2A functions in all the eukaryotic systems tested to date and has already been applied, with great success, to a broad range of biotechnological applications: from plant metabolome engineering to the expression of T-cell receptor complexes, monoclonal antibodies or heterodimeric cytokines in animals.
UR - http://www.scopus.com/inward/record.url?scp=31444448624&partnerID=8YFLogxK
U2 - 10.1016/j.tibtech.2005.12.006
DO - 10.1016/j.tibtech.2005.12.006
M3 - Review article
C2 - 16380176
AN - SCOPUS:31444448624
SN - 0167-7799
VL - 24
SP - 68
EP - 75
JO - Trends in Biotechnology
JF - Trends in Biotechnology
IS - 2
ER -